EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Radiolabeling of Glu-Urea-Lys with 99m Tc-Tricarbonyl-Imidazole-Bathophenanthroline Disulfonate Chelation System and Biological Evaluation as Prostate-Specific Membrane Antigen Inhibitor

Dara Hatamabadi iD, Safura Joukar, Pegah Shakeri, Saeed Balalaie, Abdolreza Yazdani, Mona Khoramjouy, Seyed Mohammad Mazidi, Farzad Kobarfard, Mona Mosayebnia, Negar Bozorgchami, Mahnaz Ahmadi iD, Seyed Mohammad Ayyoubzadeh iD und 1 weitere

Cancer Biotherapy and Radiopharmaceuticals · 2023

DOI: 10.1089/cbr.2023.0024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2023. Verfasst von Dara Hatamabadi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry and Radiopharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Antigens, Surface, Glutamate Carboxypeptidase II. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, SurfaceGlutamate Carboxypeptidase IIAnimalsHumansMaleMiceArtificial IntelligenceChelating AgentsImidazolesLigandsProstateRadiopharmaceuticalsTechnetiumTissue DistributionUreaPhenanthrolines

Stichwörter der Autor:innen

99mTc-tricarbonylGlu-Urea-Lys (EUK)PSMA inhibitorartificial intelligencedocking studiesprostate cancer

Substanzen

Chelating AgentsImidazolesLigandsRadiopharmaceuticalsTechnetiumUreaAntigens, SurfaceGlutamate Carboxypeptidase IIbathophenanthroline disulfonic acidPhenanthrolines

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry and Radiopharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Peptide Chemistry Research Institute, K. N. Toosi University of Technolology, Tehran, Iran.
  • Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran.
  • Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Dara Hatamabadi, Mahnaz Ahmadi, Seyed Mohammad Ayyoubzadeh, Soraya Shahhosseini

Zitieren

APA

Hatamabadi, D., Joukar, S., Shakeri, P., Balalaie, S., Yazdani, A., Khoramjouy, M., Mazidi, S. M., Kobarfard, F., Mosayebnia, M., Bozorgchami, N., Ahmadi, M., Ayyoubzadeh, S. M., & Shahhosseini, S. (2023). Synthesis and Radiolabeling of Glu-Urea-Lys with 99m Tc-Tricarbonyl-Imidazole-Bathophenanthroline Disulfonate Chelation System and Biological Evaluation as Prostate-Specific Membrane Antigen Inhibitor. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2023.0024

Vancouver

Hatamabadi D, Joukar S, Shakeri P, Balalaie S, Yazdani A, Khoramjouy M, et al. Synthesis and Radiolabeling of Glu-Urea-Lys with 99m Tc-Tricarbonyl-Imidazole-Bathophenanthroline Disulfonate Chelation System and Biological Evaluation as Prostate-Specific Membrane Antigen Inhibitor. Cancer Biotherapy and Radiopharmaceuticals. 2023. doi:10.1089/cbr.2023.0024

BibTeX
@article{Hatamabadi2023,
  author = {Hatamabadi, Dara and Joukar, Safura and Shakeri, Pegah and Balalaie, Saeed and Yazdani, Abdolreza and Khoramjouy, Mona and Mazidi, Seyed Mohammad and Kobarfard, Farzad and Mosayebnia, Mona and Bozorgchami, Negar and Ahmadi, Mahnaz and Ayyoubzadeh, Seyed Mohammad and Shahhosseini, Soraya},
  title = {Synthesis and Radiolabeling of Glu-Urea-Lys with 99m Tc-Tricarbonyl-Imidazole-Bathophenanthroline Disulfonate Chelation System and Biological Evaluation as Prostate-Specific Membrane Antigen Inhibitor},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2023},
  doi = {10.1089/cbr.2023.0024}
}
Kostenlos starten →